Navigation Links
Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System

SAN JOSE, Calif., Oct. 31, 2011 /PRNewswire/ -- Baxano, Inc., a Silicon Valley based medical device company and manufacturer of the iO-Flex® System for spinal decompression surgery, announces a rapid expansion of its sales infrastructure to meet the surging demand for its products.

This continued expansion in the field infrastructure will help increase Baxano's reach into new and existing accounts throughout the U.S. while providing greater support to surgeons in their efforts to help treat a growing number of patients suffering from lumbar spinal stenosis (LSS), a disease that currently affects roughly 3 million adults annually.

Tony Recupero, President & CEO of Baxano, commented, "We are very optimistic about Baxano's current success and future prospects.  Our monthly sales have grown 300% during the first three quarters of 2011 and Q4 is showing even stronger growth rates.  We are expanding our sales coverage so that we can continue to deliver this very innovative technology to surgeons who are treating LSS patients."

Baxano's flagship iO-Flex® System is the first minimally invasive set of flexible instruments designed to target lumbar stenosis in the central canal, lateral recess and neural foramen, with minimal disruption to the patient's healthy anatomy. It is the only treatment alternative that is able to reach and remove tissue that creates pressure on multiple nerve roots through a single incision.

The Company is also currently enrolling patients in two separate post-market trials (iO-Flex Study and STRiDE) to further demonstrate outcomes and economics relative to traditional treatments for LSS.

About Baxano, Inc.

Baxano, Inc., based in San Jose, California, is a privately held company which was founded in 2005 with the vision to create flexible tools to provide precision lumbar decompression from the "inside out."  These important platform technologies will form the basis for future product offerings.  

Baxano's mission is to develop innovative tools that restore spine function, preserve healthy tissue, and enable a better quality of life for the patients we serve.

Along with our dedication to advanced technology development, Baxano is focused on providing exceptional value to patients, customers, investors and employees. For more information about Baxano and its products, please visit:

Amie Borgstrom
Vice President, Marketing
Phone: 408-514-2217

SOURCE Baxano, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxano, Inc. Names George A. Harter, Jr. as Chief Financial Officer
2. Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards
3. Baxano, Inc. Announces Close of $30 Million Series C Funding
4. GNS Healthcare, Inc. Expands Senior Management Team to Leverage the Rapidly Growing Opportunities for Big Data in Healthcare Management
5. Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad
6. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
7. Marken Rapidly Responds to Global Supply Chain Security Measures
8. Installation of Next Generation Proton Therapy System Progressing Rapidly
9. endpoint Launches PULSE 2.0 Allowing Clinical Research Teams to Save Additional Time and Money By Rapidly Deploying Studies With Custom Reporting
10. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
11. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
Breaking Medicine News(10 mins):